ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Pretax margin (%)

TERUMO CORPORATION (4543)

Market cap
¥3.29T
P/E ratio
19.8x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202615.7+5.57%
Mar 31, 202514.9-2.35%
Mar 31, 202415.3+7.89%
Mar 31, 202314.2-13.03%
Mar 31, 202216.3+2.96%
Mar 31, 202115.8-6.60%
Mar 31, 202016.9-1.19%
Mar 31, 201917.1-5.56%
Mar 31, 201818.1+36.07%
Mar 31, 201713.3-4.23%
Mar 31, 201613.9-3.65%
Mar 31, 201514.4+5.84%
Mar 31, 201413.7+6.90%
Mar 31, 201312.8-16.53%
Mar 31, 201215.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat